Kestra Medical Technologies
KMTS
80 hedge funds and large institutions have $1.15B invested in Kestra Medical Technologies in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 16 closing their positions.
209% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 11
46% more capital invested
Capital invested by funds: $785M → $1.15B (+$364M)
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
10% more funds holding
Funds holding: 73 → 80 (+7)
1.8% more ownership
Funds ownership: 92.26% → 94.07% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.1M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$12.1M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$7.07M |
| 5 |
Millennium Management
New York
|
+$3.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$25M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$21.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$3.52M |
| 4 |
RI
RTW Investments
New York
|
-$3.32M |
| 5 |
Holocene Advisors
New York
|
-$2.17M |
KMTS Hedge Fund Activity: Q3 2025 in Review
80 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q3 2025, worth a combined $1.15B — up 46% from $785M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new KMTS positions and 16 closed out — a net gain of 7 holders — while 34 added to existing stakes and 11 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $28.3M. The largest seller was Citadel Advisors, exiting entirely with an estimated $25M sold.
- 80 institutional investors held Kestra Medical Technologies (KMTS) as of Q3 2025, up from 73 in Q2 2025.
- Funds reported $1.15B of Kestra Medical Technologies stock for Q3 2025, up 46% quarter-over-quarter.
- 23 funds opened new Kestra Medical Technologies positions in Q3 2025 and 16 closed out, a net change of +7 holders.
- The largest Kestra Medical Technologies buyer in Q3 2025 was Fidelity Investments, an estimated $28.3M added.
- The largest Kestra Medical Technologies seller in Q3 2025 was Citadel Advisors, an estimated $25M sold.
Based on aggregated 13F filings for Q3 2025.